# Soluna Holdings, Inc: financial statements, quarterly

SLNH · Nasdaq · CIK 64463 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slnh.md) · [Financials](/companies/slnh/financials.md) · [Filings](/companies/slnh/filings.md) · [Insiders](/companies/slnh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slnh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.8](/filings/0001493152-23-041073.md) | [10.1 d](/filings/0001641172-25-001756.md) | [12.5](/filings/0001641172-25-010886.md) | [9.7](/filings/0001641172-25-024045.md) | [7.5](/filings/0001493152-25-023503.md) | [8.3 d](/filings/0001628280-26-021847.md) | [5.9](/filings/0001628280-26-035538.md) | [6.2](/filings/0001628280-26-056702.md) | [8.4](/filings/0001493152-25-023503.md) | [9.2 d](/filings/0001628280-26-021847.md) | [9.4](/filings/0001628280-26-035538.md) | [15.1](/filings/0001628280-26-056702.md) |
| Cost of revenue | $m | [4.4](/filings/0001493152-24-045722.md) | [5.8 d](/filings/0001641172-25-001756.md) | [5.6](/filings/0001641172-25-010886.md) | [5.6](/filings/0001641172-25-024045.md) | [8.9](/filings/0001493152-25-023503.md) | [8.6 d](/filings/0001628280-26-021847.md) | [4.8](/filings/0001628280-26-035538.md) | [5.0](/filings/0001628280-26-056702.md) | [6.1](/filings/0001493152-25-023503.md) | [7.4 d](/filings/0001628280-26-021847.md) | [7.5](/filings/0001628280-26-035538.md) | [14.3](/filings/0001628280-26-056702.md) |
| Gross profit | $m | not reported | not reported | [5.7](/filings/0001641172-25-010886.md) | [3.3](/filings/0001641172-25-024045.md) | [(2.9)](/filings/0001493152-25-023503.md) | [(29.8) d](/filings/0001628280-26-021847.md) | [0.3](/filings/0001628280-26-035538.md) | [0.4](/filings/0001628280-26-056702.md) | [0.8](/filings/0001493152-25-023503.md) | [0.6 d](/filings/0001628280-26-021847.md) | [0.5](/filings/0001628280-26-035538.md) | [(1.3)](/filings/0001628280-26-056702.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [5.1](/filings/0001493152-24-045722.md) | [6.6 d](/filings/0001641172-25-001756.md) | [6.4](/filings/0001641172-25-010886.md) | [7.8](/filings/0001641172-25-024045.md) | [7.7](/filings/0001493152-25-023503.md) | [6.4 d](/filings/0001628280-26-021847.md) | [8.4](/filings/0001628280-26-035538.md) | [7.8](/filings/0001628280-26-056702.md) | [10.1](/filings/0001493152-25-023503.md) | [13.9 d](/filings/0001628280-26-021847.md) | [18.5](/filings/0001628280-26-035538.md) | [17.6](/filings/0001628280-26-056702.md) |
| Operating income | $m | [(3.7)](/filings/0001493152-24-045722.md) | [(2.4) d](/filings/0001641172-25-001756.md) | [0.4](/filings/0001641172-25-010886.md) | [(3.7)](/filings/0001641172-25-024045.md) | [(9.0)](/filings/0001493152-25-023503.md) | [(35.2) d](/filings/0001628280-26-021847.md) | [(7.2)](/filings/0001628280-26-035538.md) | [(6.6)](/filings/0001628280-26-056702.md) | [(7.8)](/filings/0001493152-25-023503.md) | [(12.1) d](/filings/0001628280-26-021847.md) | [(16.6)](/filings/0001628280-26-035538.md) | [(16.9)](/filings/0001628280-26-056702.md) |
| Interest expense | $m | [0.5](/filings/0001493152-24-045722.md) | [0.4 d](/filings/0001641172-25-001756.md) | [0.4](/filings/0001641172-25-010886.md) | [0.4](/filings/0001641172-25-024045.md) | [0.8](/filings/0001493152-25-023503.md) | [0.8 d](/filings/0001641172-25-001756.md) | [0.8](/filings/0001641172-25-010886.md) | [1.2](/filings/0001641172-25-024045.md) | [1.2](/filings/0001493152-25-023503.md) | [1.6 d](/filings/0001628280-26-021847.md) | [1.5](/filings/0001628280-26-035538.md) | [3.2](/filings/0001628280-26-056702.md) |
| Income tax | $m | [0.6](/filings/0001493152-24-045722.md) | [(0.5) d](/filings/0001641172-25-001756.md) | [(0.5)](/filings/0001641172-25-010886.md) | [(0.6)](/filings/0001641172-25-024045.md) | [(0.5)](/filings/0001493152-25-023503.md) | [(0.7) d](/filings/0001628280-26-021847.md) | [(0.4)](/filings/0001628280-26-035538.md) | [(0.6)](/filings/0001628280-26-056702.md) | [(0.7)](/filings/0001493152-25-023503.md) | [(0.6) d](/filings/0001628280-26-021847.md) | [(0.6)](/filings/0001628280-26-035538.md) | [(0.5)](/filings/0001628280-26-056702.md) |
| Net income | $m | [(6.7)](/filings/0001493152-24-045722.md) | [(5.0)](/filings/0001493152-24-045722.md) | [(5.3)](/filings/0001641172-25-010886.md) | [(10.9)](/filings/0001641172-25-024045.md) | [(7.2)](/filings/0001493152-25-023503.md) | [(38.5)](/filings/0001493152-25-023503.md) | [(7.6)](/filings/0001628280-26-035538.md) | [(7.4)](/filings/0001628280-26-056702.md) | [(24.0)](/filings/0001493152-25-023503.md) | [(16.1)](/filings/0001628280-26-056702.md) | [(17.5)](/filings/0001628280-26-035538.md) | [(20.7)](/filings/0001628280-26-056702.md) |
| Diluted EPS | $ per share | [(5.96)](/filings/0001493152-24-045722.md) | not reported | [(2.62)](/filings/0001641172-25-010886.md) | [(3.62)](/filings/0001628280-26-021847.md) | [(1.56)](/filings/0001628280-26-021847.md) | not reported | [(1.21)](/filings/0001628280-26-035538.md) | [(0.93)](/filings/0001628280-26-056702.md) | [(1.14)](/filings/0001493152-25-023503.md) | not reported | [(0.24)](/filings/0001628280-26-035538.md) | [(0.18)](/filings/0001628280-26-056702.md) |
| Basic EPS | $ per share | [(5.96)](/filings/0001493152-24-045722.md) | not reported | [(2.62)](/filings/0001641172-25-010886.md) | [(3.62)](/filings/0001628280-26-021847.md) | [(1.56)](/filings/0001628280-26-021847.md) | not reported | [(1.21)](/filings/0001628280-26-035538.md) | [(0.93)](/filings/0001628280-26-056702.md) | [(1.14)](/filings/0001493152-25-023503.md) | not reported | [(0.24)](/filings/0001628280-26-035538.md) | [(0.18)](/filings/0001628280-26-056702.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-07-22) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.4](/filings/0001641172-25-001756.md) | [8.4](/filings/0001493152-24-020047.md) | [9.6](/filings/0001493152-24-032123.md) | not reported | [8.8](/filings/0001493152-24-045722.md) | [7.8](/filings/0001628280-26-021847.md) | [9.2](/filings/0001641172-25-010886.md) | [9.9](/filings/0001641172-25-024045.md) | [51.4](/filings/0001493152-25-023503.md) | [76.4](/filings/0001628280-26-056702.md) | [68.6](/filings/0001628280-26-035538.md) | [113](/filings/0001628280-26-056702.md) |
| Current assets | $m | [14.3](/filings/0001641172-25-001756.md) | [17.0](/filings/0001493152-24-020047.md) | [27.5](/filings/0001493152-24-032123.md) | not reported | [18.5](/filings/0001493152-24-045722.md) | [13.5](/filings/0001628280-26-021847.md) | [15.8](/filings/0001641172-25-010886.md) | [17.0](/filings/0001641172-25-024045.md) | [66.4](/filings/0001493152-25-023503.md) | [92.1](/filings/0001628280-26-056702.md) | [90.7](/filings/0001628280-26-035538.md) | [135](/filings/0001628280-26-056702.md) |
| Total assets | $m | [91.3](/filings/0001641172-25-001756.md) | [90.6](/filings/0001493152-24-020047.md) | [98.7](/filings/0001493152-24-032123.md) | not reported | [97.3](/filings/0001493152-24-045722.md) | [88.0](/filings/0001628280-26-021847.md) | [90.0](/filings/0001641172-25-010886.md) | [92.0](/filings/0001641172-25-024045.md) | [152](/filings/0001493152-25-023503.md) | [188](/filings/0001628280-26-056702.md) | [190](/filings/0001628280-26-035538.md) | [294](/filings/0001628280-26-056702.md) |
| Current liabilities | $m | [28.2](/filings/0001641172-25-001756.md) | [32.5](/filings/0001493152-24-020047.md) | [32.5](/filings/0001493152-24-032123.md) | not reported | [31.3](/filings/0001493152-24-045722.md) | [47.9](/filings/0001628280-26-021847.md) | [47.6](/filings/0001641172-25-010886.md) | [47.9](/filings/0001641172-25-024045.md) | [56.2](/filings/0001493152-25-023503.md) | [49.2](/filings/0001628280-26-056702.md) | [51.9](/filings/0001628280-26-035538.md) | [65.4](/filings/0001628280-26-056702.md) |
| Total liabilities | $m | [37.9](/filings/0001641172-25-001756.md) | [41.8](/filings/0001493152-24-020047.md) | [48.7](/filings/0001493152-24-032123.md) | not reported | [45.8](/filings/0001493152-24-045722.md) | [60.7](/filings/0001628280-26-021847.md) | [63.1](/filings/0001641172-25-010886.md) | [62.6](/filings/0001641172-25-024045.md) | [78.6](/filings/0001493152-25-023503.md) | [75.7](/filings/0001628280-26-056702.md) | [76.1](/filings/0001628280-26-035538.md) | [81.8](/filings/0001628280-26-056702.md) |
| Long-term debt | $m | not reported | not reported | [9.0](/filings/0001493152-24-032123.md) | [2.2](/filings/0001628280-26-021847.md) | [8.1](/filings/0001493152-24-045722.md) | [7.1](/filings/0001628280-26-021847.md) | [10.2](/filings/0001641172-25-010886.md) | [10.0](/filings/0001641172-25-024045.md) | [13.3](/filings/0001493152-25-023503.md) | [17.9](/filings/0001628280-26-056702.md) | [15.9](/filings/0001628280-26-035538.md) | [3.0](/filings/0001628280-26-056702.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [14.4](/filings/0001628280-26-021847.md) | not reported | not reported | not reported | [8.9](/filings/0001628280-26-056702.md) | [10.0](/filings/0001628280-26-035538.md) | [30.1](/filings/0001628280-26-056702.md) |
| Shareholders' equity | $m | [26.5](/filings/0001641172-25-001756.md) | [21.5](/filings/0001493152-24-020047.md) | [24.4](/filings/0001493152-24-032123.md) | not reported | [20.9](/filings/0001493152-24-045722.md) | [(12.5)](/filings/0001628280-26-021847.md) | [(16.1)](/filings/0001641172-25-010886.md) | [(19.5)](/filings/0001641172-25-024045.md) | [14.5](/filings/0001493152-25-023503.md) | [53.6](/filings/0001628280-26-056702.md) | [47.2](/filings/0001628280-26-035538.md) | [156](/filings/0001628280-26-056702.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.6) d](/filings/0001493152-24-045722.md) | [1.4 d](/filings/0001641172-25-001756.md) | [3.9](/filings/0001641172-25-010886.md) | [(7.3) d](/filings/0001641172-25-024045.md) | [0.1 d](/filings/0001493152-25-023503.md) | [(1.7) d](/filings/0001628280-26-021847.md) | [(0.2)](/filings/0001628280-26-035538.md) | [(1.1) d](/filings/0001628280-26-056702.md) | [(2.2) d](/filings/0001493152-25-023503.md) | [(5.7) d](/filings/0001628280-26-021847.md) | [(6.4)](/filings/0001628280-26-035538.md) | [(5.2) d](/filings/0001628280-26-056702.md) |
| Capital expenditure | $m | [9.6 d](/filings/0001493152-24-045722.md) | [0.2 d](/filings/0001641172-25-001756.md) | [0.5](/filings/0001641172-25-010886.md) | [(0.2) d](/filings/0001641172-25-024045.md) | [3.4 d](/filings/0001493152-25-023503.md) | [5.1 d](/filings/0001628280-26-021847.md) | [3.5](/filings/0001628280-26-035538.md) | [4.3 d](/filings/0001628280-26-056702.md) | [9.2 d](/filings/0001493152-25-023503.md) | [11.1 d](/filings/0001628280-26-021847.md) | [2.6](/filings/0001628280-26-035538.md) | [6.9 d](/filings/0001628280-26-056702.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-035538.md) | [0.0 d](/filings/0001628280-26-056702.md) | [0.2 d](/filings/0001493152-25-023503.md) | [(0.1) d](/filings/0001628280-26-021847.md) | [0.1](/filings/0001628280-26-035538.md) | [0.1 d](/filings/0001628280-26-056702.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.6](/filings/0001493152-23-041073.md) | [0.9](/filings/0001493152-24-020047.md) | [1.1](/filings/0001493152-24-032123.md) | [1.4](/filings/0001493152-24-045722.md) | [2.8](/filings/0001641172-25-010886.md) | [3.7](/filings/0001628280-26-021847.md) | [6.4](/filings/0001628280-26-021847.md) | [8.7](/filings/0001628280-26-035538.md) | [11.1](/filings/0001628280-26-056702.md) | [27.0](/filings/0001493152-25-023503.md) | [84.1](/filings/0001628280-26-035538.md) | [131](/filings/0001628280-26-056702.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 244,590,575 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056702.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.